Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3268152 | Endocrinology and Metabolism Clinics of North America | 2007 | 14 Pages |
Abstract
In this article, the conflicting data concerning the androgen axis and prostate cancer development are reviewed in addition to how this pathway may be exploited to prevent the development of prostate cancer. The expanding role of hormone ablative therapy alone or in conjunction with standard therapies, the controversies of timing of therapy, and the completeness of ablation and its use on an intermittent basis are reviewed.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Christopher MD, Simon J. MD,